BeStock  
Stocks › Biotechnology › LGND

Ligand Pharmaceuticals LGND

US equityMarket cap rank #1897Biotechnology
$286.85 −$0.09 (-0.03%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $286.85 0.00%
Open$285.21
Prev close$286.94
Day range$282.36 – $291.36
Volume259.8K
Market cap$5.74B
P/E (TTM)115.2
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings124.0x
CheapRich

Near the top of its 5-year range · 99th percentile, 5-year average -2.0x

#2869 of 2994 stocks by PE (1 = cheapest)

Price / book6.4x
CheapRich

Near the top of its 5-year range · 99th percentile, 5-year average 2.8x

#4634 of 5331 stocks by PB (1 = cheapest)

Price / sales24.3x
CheapRich

Near the top of its 5-year range · 99th percentile, 5-year average 11.3x

#4768 of 5155 stocks by PS (1 = cheapest)

P/E over five years

-547x-306x-64x177xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$284.08
Price vs. fair value+1.0%Close to the estimate
Star rating★★★☆☆
Economic moatNarrow
UncertaintyHigh
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 6.42 – 2.80 99% (pricier than usual) #4634 of 5331 (1 = cheapest)
PE 124.01 68.95 -1.95 99% (pricier than usual) #2869 of 2994 (1 = cheapest)
PS 24.33 17.63 11.29 99% (pricier than usual) #4768 of 5155 (1 = cheapest)

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on LGND.

Sign in to join the discussion.

Scroll to Top